Skip to main content
VCbacked
Log inGet Started

NewcelX (formerly NLS Pharma)

Stans, Switzerland

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

$1.4M raised
Apr 2026
Post-IPO Equity
BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

Top Investors

Biotechnology Value FundYorkville Advisors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NewcelX (formerly NLS Pharma)

How much funding has NewcelX (formerly NLS Pharma) raised?
NewcelX (formerly NLS Pharma) has raised $1.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Who are NewcelX (formerly NLS Pharma)'s investors?
NewcelX (formerly NLS Pharma)'s investors include Biotechnology Value Fund, Yorkville Advisors.
Where is NewcelX (formerly NLS Pharma) headquartered?
NewcelX (formerly NLS Pharma) is headquartered in Stans, Switzerland.
What does NewcelX (formerly NLS Pharma) do?
NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.
What stage is NewcelX (formerly NLS Pharma) at?
NewcelX (formerly NLS Pharma) is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"NewcelX (formerly NLS Pharma) — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/newcelx-formerly-nls-pharma. Accessed July 4, 2026.
APA
VCBacked. (2026). NewcelX (formerly NLS Pharma) — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/newcelx-formerly-nls-pharma
Wikipedia (cite web)
{{cite web |title=NewcelX (formerly NLS Pharma) — Funding & Investors |url=https://www.vcbacked.co/company/newcelx-formerly-nls-pharma |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M